M. Spitzer et al., Enantio-selective cognitive and brain activation effects of N-ethyl-3,4-methylenedioxyamphetamine in humans, NEUROPHARM, 41(2), 2001, pp. 263-271
In a randomised double-blind trial the subjective, neuropsychological and b
rain activation effects of the two enantiomers of the MDMA (ecstasy-) like
drug N-ethyl-3,4-methylenedioxyamphetamine (NIDE) were studied in five norm
al subjects using functional magnetic resonance imaging (fMRI). (S)-MDE pro
duced elevated mood, impairments in conceptually driven cognition and marke
d right frontal activation. In contrast, (R)-MDE produced increased depress
ion, enhanced visual feature processing, and activation of visual cortical
and left frontal areas. Plasma concentrations were higher for the (R)-enant
iomer. The so-called entactogenic effects of MDE are likely to be caused by
the (S)-enantiomer, whereas (R)-MDE appears to be responsible for neurotox
ic effects. (C) 2001 Elsevier Science Ltd. All rights reserved.